Environmental influences on antibody-enhanced dengue disease outcomes

Memorias do Instituto Oswaldo Cruz

Volumn 107, Issue 8, 2012, Pages 1021-1029

  Diniz, Daniel Guerreiro ^a   Fôro, César Augusto Raiol ^a   Turiel, Maíra C Pereira ^a   Sosthenes, Marcia CK ^a   Demachki, Sâmia ^a   Gomes, Giovanni Freitas ^a   Rego, Carla M Damasceno ^a   Magalhães, Marina Cutrim ^a   Pinho, Brunno Gomes ^b   Ramos, Juliana Pastana ^c   Casseb, Samir M Moraes ^d   Brito, Maysa de Vasconcelos ^d   da Silva, Eliana Vieira Pinto ^d   Nunes, Marcio Roberto Teixeira ^d   Diniz, José Antonio Picanço ^d   Cunningham, Colm ^e   Perry, Victor Hugh ^f   Vasconcelos, Pedro F Costa ^c,d   Diniz, Cristovam W Picanço ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b Centro de Estudos Superiores do Estado do Pará   (Brazil)

^c UNIVERSIDADE DO ESTADO DO PARÁ   (Brazil)

^d INSTITUTO EVANDRO CHAGAS   (Brazil)

^e TRINITY COLLEGE DUBLIN   (Ireland)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Antibody enhanced dengue disease; Enriched environment; Experimental dengue infection; Serial dengue infection; T lymphocytes

Indexed keywords

VIRUS ANTIBODY;

ANIMAL; ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; B LYMPHOCYTE; COMPARATIVE STUDY; DENGUE; DENGUE VIRUS; ECOLOGY; FEMALE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; T LYMPHOCYTE; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT ENHANCEMENT; B-LYMPHOCYTES; DENGUE; DENGUE VIRUS; ECOLOGY; FEMALE; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTES;

ANIMALIA; DENGUE VIRUS;

EID: 84871741502     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762012000800010     Document Type: Article

References (42)

1. Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, Mehlhop E, Johnson S, Diamond MS, Beatty PR, Harris E 2010. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 6: e1000790.
2. Barreto DF, Takiya CM, Schatzmayr HG, Nogueira RMR, Farias-Filho J da C, Barth OM 2007. Histopathological and ultrastructural aspects of mice lungs experimentally infected with dengue virus serotype 2. Mem Inst Oswaldo Cruz 102: 175-182.
3. Beaumier CM, Mathew A, Bashyam HS, Rothman AL 2008. Crossreactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner. J Infect Dis 197: 608-617.
4. + T cells. Viral Immunol 23: 477-485.
5. Boonnak K, Dambach KM, Donofrio GC, Tassaneetrithep B, Marovich MA 2011. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J Virol 85: 1671-1683.
6. Brown MG, Hermann LL, Issekutz AC, Marshall JS, Rowter D, Al-Afif A, Anderson R 2011. Dengue virus infection of mast cells triggers endothelial cell activation. J Virol 85: 1145-1150.
7. Cunningham C, Campion S, Lunnon K, Murray CL, Woods JFC, Deacon RMJ, Rawlins JNP, Perry VH 2009. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry 65: 304-312.
8. Daughaday CC, Brandt WE, McCown JM, Russell PK 1981. Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Infect Immun 32: 469-473.
9. de Miranda AS, Rodrigues DH, Amaral DC, de Lima Campos RD, Cisalpino D, Vilela MC, Lacerda-Queiroz N, de Souza KP, Vago JP, Campos MA, Kroon EG, da Gloria de Souza D, Teixeira MM, Teixeira AL, Rachid MA 2012. Dengue-3 encephalitis promotes anxiety-like behavior in mice. Behav Brain Res 230: 237-242.
10. de-Oliveira-Pinto LM, Gandini M, Freitas LP, Siqueira MM, Marinho CF, Setúbal S, Kubelka CF, Cruz OG, de Oliveira SA 2012. Profile of circulating levels of IL-1Ra, CXCL10/IP-10, CCL4/MIP1β and CCL2/MCP-1 in dengue fever and parvovirosis. Mem Inst Oswaldo Cruz 107: 48-56.
11. de Sousa AA, Reis R, Bento-Torres J, Trevia N, Lins NA, Passos A, Santos Z, Diniz JA, Vasconcelos PF, Cunningham C, Perry VH, Diniz CW 2011. Influence of enriched environment on viral encephalitis outcomes: behavioral and neuropathological changes in albino Swiss mice. PLoS ONE 6: e15597.
12. dos Santos HW, Poloni TR, Souza KP, Muller VD, Tremeschin F, Nali LC, Fantinatti LR, Amarilla AA, Castro HL, Nunes MR, Casseb SM, Vasconcelos PF, Badra SJ, Figueiredo LT, Aquino VH 2008. A simple one-step real-time RT-PCR for diagnosis of dengue virus infection. J Med Virol 80: 1426-1433.
13. Ferreira GP, Figueiredo LB, Coelho LF, PA Jr S, Cecilio AB, Ferreira PC, Bonjardim CA, Arantes RM, Campos MA, Kroon EG 2010. Dengue virus 3 clinical isolates show different patterns of virulence in experimental mice infection. Microbes Infect 12: 546-554.
14. + T cells from naturally acquired primary dengue virus infection are highly cross-reactive. Immunol Cell Biol 89: 122-129.
15. Furuta T, Murao LA, Lan NT, Huy NT, Huong VT, Thuy TT, Tham VD, Nga CT, Ha TT, Ohmoto Y, Kikuchi M, Morita K, Yasunami M, Hirayama K, Watanabe N 2012. Association of mast cell-derived VEGF and proteases in dengue shock syndrome. PLoS Negl Trop Dis 6: e1505.
16. Gibbons RV, Kalanarooj S, Jarman RG, Nisalak A, Vaughn DW, Endy TP, Mammen Jr MP, Srikiatkhachorn A 2007. Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever and serotype sequences. Am J Trop Med Hyg 77: 910-913.
17. Guabiraba R, Marques RE, Besnard AG, Fagundes CT, Souza DG, Ryffel B, Teixeira MM 2010. Role of the chemokine receptors CCR1, CCR2 and CCR4 in the pathogenesis of experimental dengue infection in mice. PLoS ONE 5: e15680.
18. Gubler DJ, Meltzer M 1999. Impact of dengue/dengue hemorrhagic fever on the developing world. Adv Virus Res 53: 35-70.
19. Halstead SB 2007. Dengue. Lancet 370: 1644-1652.
20. Hober D, Poli L, Roblin B, Gestas P, Chungue E, Granic G, Imbert P, Pecarere JL, Vergez-Pascal R, Wattre P, et al. 1993. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am J Trop Med Hyg 48: 324-331.
21. Ip PP, Liao F 2010. Resistance to dengue virus infection in mice is potentiated by CXCL10 and is independent of CXCL10-mediated leukocyte recruitment. J Immunol 184: 5705-5714.
22. Jessie K, Fong MY, Devi S, Lam SK, Wong KT 2004. Localization of dengue virus in naturally infected human tissues by immunohistochemistry and in situ hybridization. J Infect Dis 189: 1411-1418.
23. Kangwanpong D, Bhamarapravati N, Lucia HL 1995. Diagnosing dengue virus infection in archived autopsy tissues by means of the in situ PCR method: a case report. Clin Diagn Virol 3: 165-172.
24. Kinoshita D, Cohn DW, Costa-Pinto FA, de Sa-Rocha LC 2009. Behavioral effects of LPS in adult, middle-aged and aged mice. Physiol Behav 96: 328-332.
25. Kurane I, Ennis FE 1992. Immunity and immunopathology in dengue virus infections. Semin Immunol 4: 121-127.
26. + T cell survival promoted by toll-like receptor ligands. Hepatobiliary Pancreat Dis Int 9: 376-383.
27. Mathew A, Rothman AL 2008. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev 225: 300-313.
28. Nguyen TH, Lei HY, Nguyen TL, Lin YS, Huang KJ, Le BL, Lin CF, Yeh TM, Do QH, Vu TQ, Chen LC, Huang JH, Lam TM, Liu CC, Halstead SB 2004. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 189: 221-232.
29. Rothman AL 2009. T lymphocyte responses to heterologous secondary dengue virus infections. Ann NY Acad Sci 1171: e36-41.
30. Rothman AL 2010. Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis. Curr Top Microbiol Immunol 338: 83-98.
31. Ruangjirachuporn W, Boonpucknavig S, Nimmanitya S 1979. Circulating immune complexes in serum from patients with dengue haemorrhagic fever. Clin Exp Immunol 36: 46-53.
32. Saper CB, Sawchenko PE 2003. Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry. J Comp Neurol 465: 161-163.
33. Sergerie Y, Boivin G, Gosselin D, Rivest S 2007. Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice. J Infect Dis 195: 817-825.
34. Shu SY, Ju G, Fan LZ 1988. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 85: 169-171.
35. Suaya JA, Shepard DS, Siqueira JB, Martelli CT, Lum LC, Tan LH, Kongsin S, Jiamton S, Garrido F, Montoya R, Armien B, Huy R, Castillo L, Caram M, Sah BK, Sughayyar R, Tyo KR, Halstead SB 2009. Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. Am J Trop Med Hyg 80: 846-855.
36. Tan GK, Ng JK, Trasti SL, Schul W, Yip G, Alonso S 2010. A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice. PLoS Negl Trop Dis 4: e672.
37. Teeling JL, Cunningham C, Newman TA, Perry VH 2010. The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: implications for a role of COX-1. Brain Behav Immun 24: 409-419.
38. Thomas SJ, Strickman D, Vaughn DW 2003. Dengue epidemiology: virus epidemiology, ecology and emergence. Adv Virus Res 61: 235-289.
39. van Praag, Kempermann G, Gage FH 2000. Neural consequences of enviromental enrichement. Nat Rev Neurosci 1: 191-198.
40. Vitarana T, de Silva H, Withana N, Gunasekera C 1991. Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever. Ceylon Med J 36: 63-65.
41. Wang WK, Chao DY, Kao CL, Wu HC, Liu YC, Li CM, Lin SC, Ho ST, Huang JH, King CC 2003. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology 305: 330-338.
42. Wang WK, Chen HL, Yang CF, Hsieh SC, Juan CC, Chang SM, Yu CC, Lin LH, Huang JH, King CC 2006. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis 43: 1023-1030.